Delivery Order SPE2DB25D3005-SPE2DB26FQBCH
- Not listed
- The Defense Logistics Agency awarded a Delivery Order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of SPIKEVAX 2025-26 pediatric vaccine (6 months to 11 years) in 0.25 milliliter syringes. Valued at $2,390.04 with firm fixed pricing, this non-set-aside competitive award is scheduled for completion by November 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfills this order as the place of performance location, leveraging its established role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of SPIKEVAX 2025-26 pediatric vaccine formulation (0.25mL syringes for ages 6-11 years) with a ceiling value of $3,152.65. This delivery order was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of November 24, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of SPIKEVAX 2025-26 (6M-11Y) SYR 0.25ML vaccine doses, with a ceiling value of $1,261.06 and an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price contract is unset-aside and reflects DLA's ongoing procurement of pediatric COVID-19 vaccines to support military healthcare systems and defense medical supply chain requirements. The...
- The Defense Logistics Agency awarded a $2,718.60 delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and up) on November 6, 2025, with completion scheduled for December 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Spikevax 2025-26 pediatric vaccine (6 months to 11 years old) in 0.25 mL syringes, with a contract ceiling value of $6,305.30 and a completion date of December 1, 2025. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026....
- The Defense Logistics Agency awarded a $2,605.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ml on October 29, 2025, with completion scheduled for November 20, 2025. This is a non-set-aside competitive award for pediatric COVID-19 vaccine delivery to support federal immunization programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $5,784.65 to AmerisourceBergen Drug Corp for the supply of SPIKEVAX 2025-26 vaccine (6 months to 11 years old formulation) in 0.25 milliliter syringes. The contract, which is not set-aside and was awarded on November 10, 2025, carries a completion date of December 3, 2025, and utilizes firm fixed pricing. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 pediatric vaccine (6 months to 11 years) in a 0.25 mL syringe formulation, with a ceiling value of $3,783.18. This firm fixed-price delivery order, awarded on October 24, 2025, with ultimate completion by November 17, 2025, carries no set-aside designation and represents a competitive award. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,953.84 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML on September 26, 2025, with a completion date of September 29, 2025. This firm fixed price delivery order represents a pediatric vaccine supply for children ages 6 months to 11 years and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.01 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) Syringe 0.25ML, a pediatric COVID-19 vaccine formulation. This firm fixed price delivery order, awarded on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB26FQBCHDelivery Order
The Defense Logistics Agency awarded a $1,213.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of SPIKEVAX 2025-26 pediatric vaccine (6-11 years, 0.25 mL syringes). The order, which is a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement with DLA, carries an ultimate completion date of December 3, 2025, and was competitively awarded without set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine vaccine procurement under AmerisourceBergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, maintains a critical role in supplying vaccines, medications, and medical supplies to military and federal healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to fulfill diverse medical procurement requirements across multiple therapeutic domains, including vaccines, specialty pharmaceuticals, and medical devices for defense and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/10/25 |